icodec

Eli Lilly Moves Closer to Bringing Diabetes Patients a Once-Weekly Insulin Alternative

Positive preliminary results for Eli Lilly’s efsitora alfa continue to build the case for this once-weekly insulin in type 2 diabetes patients. Lilly is trying to catch up to Novo Nordisk’s once weekly insulin icodec, which is commercially available in several markets around the world but is not yet approved by the FDA.

By Frank Vinluan

BioPharma

FDA Says ‘No’ to Novo Nordisk’s Once-Weekly Insulin

The FDA rejected Novo Nordisk’s biologics license application for icodec, citing questions about the manufacturing process for this once weekly insulin as well as its use by type 1 diabetes patients. But there are several high-profile FDA approvals in our recap of recent regulatory news.

By Frank Vinluan

What Healthcare Can Learn from Costco

The path forward is clear: employers must evaluate their health plan the same way they do their Saturday shopping excursion.

By Jeff Bak, Imagine360 CEO and President

Health IT

Accelerating Claim Processing: Strategies to Shorten the Life of a Claim

These strategies and practices can significantly shorten the life cycle of claims, leading to quicker resolutions and improved financial outcomes.

By Greenway Health

Eli Lilly Moves Closer to Bringing Diabetes Patients a Once-Weekly Insulin Alternative

FDA Says ‘No’ to Novo Nordisk’s Once-Weekly Insulin

What’s Keeping Healthcare CIOs Up at Night: How to Improve Patient Satisfaction by Handling Calls More Efficiently